1. Home
  2. CADL vs BALY Comparison

CADL vs BALY Comparison

Compare CADL & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$9.92

Market Cap

739.2M

Sector

Health Care

ML Signal

N/A

Logo Bally's Corporation

BALY

Bally's Corporation

N/A

Current Price

$13.86

Market Cap

711.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
BALY
Founded
1999
2004
Country
United States
United States
Employees
55
11700
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
739.2M
711.1M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
CADL
BALY
Price
$9.92
$13.86
Analyst Decision
Strong Buy
Hold
Analyst Count
9
5
Target Price
★ $21.75
$9.67
AVG Volume (30 Days)
★ 1.1M
105.1K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.62
8.37
EPS
★ N/A
N/A
Revenue
$125,000.00
★ $2,436,189,000.00
Revenue This Year
N/A
$19.05
Revenue Next Year
N/A
$8.18
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.35
$8.44
52 Week High
$14.00
$20.74

Technical Indicators

Market Signals
Indicator
CADL
BALY
Relative Strength Index (RSI) 36.74 64.38
Support Level $9.18 $12.59
Resistance Level $10.59 $14.65
Average True Range (ATR) 0.56 0.83
MACD -0.12 0.09
Stochastic Oscillator 15.26 86.62

Price Performance

Historical Comparison
CADL
BALY

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About BALY Bally's Corporation

Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.

Share on Social Networks: